Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Misoprostol dose comparison for medical management of early miscarriage
ACTRN12612000150842Phase 2Completed
- Sponsor
- Mater Mothers' Hospital
- Start
- Sep 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of misoprostol in Pregnancy loss, Early pregnancy failure (EPF) and incomplete spontaneous abortion (2 arms), sponsored by Mater Mothers' Hospital. Primary endpoints: Completion of miscarriage by ultrasound criteria and Completion of miscarriage by clinical criteria. Started Sep 2005; status: completed.
02
Drugs
misoprostol
03
Conditions
Pregnancy lossEarly pregnancy failure (EPF)incomplete spontaneous abortion
Beyond the preview
Go deeper on ACTRN12612000150842.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12612000150842.